Dual role of nitric oxide in pancreatic β-cells

Yukiko Kurohane Kaneko1, Tomohisa Ishikawa

  • 1Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, Japan.

Insights

Nitric oxide (NO) produced by constitutive nitric oxide synthase (cNOS) in pancreatic beta cells has complex roles in insulin secretion and apoptosis. Its effects depend on concentration, influencing type 1 diabetes progression.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Inducible nitric oxide synthase (iNOS) is implicated in pancreatic beta-cell degeneration in type 1 diabetes.
  • Emerging evidence suggests constitutive nitric oxide synthase (cNOS) isoforms (NOS1 and NOS3) are present in pancreatic beta-cells.
  • The precise functions of cNOS-derived nitric oxide (NO) in beta-cells remain incompletely understood and are a subject of ongoing research.

Purpose of the Study:

  • To review the current understanding of nitric oxide's roles in pancreatic beta-cells.
  • To specifically focus on the contributions of constitutive nitric oxide synthase (cNOS)-derived NO.
  • To elucidate the concentration-dependent differential effects of NO on beta-cell function and survival.

Main Methods:

  • Literature review of existing studies on nitric oxide synthase (NOS) in pancreatic beta-cells.
  • Analysis of research investigating the presence and function of NOS1 and NOS3 in beta-cells.
  • Synthesis of data on the effects of varying nitric oxide concentrations on insulin secretion and apoptosis.

Main Results:

  • Nitric oxide (NO) exhibits dual regulatory roles in insulin secretion, acting both positively and negatively.
  • NO demonstrates opposing effects on beta-cell apoptosis, exhibiting both anti- and pro-apoptotic activities.
  • These diverse biological activities of NO are critically dependent on its concentration within the beta-cells.

Conclusions:

  • Constitutive nitric oxide synthase (cNOS)-derived NO plays a significant, albeit complex, role in pancreatic beta-cell physiology.
  • The concentration of NO is a key determinant of its functional outcomes, including insulin secretion and cell survival.
  • Further research is warranted to fully delineate the therapeutic potential of modulating NO signaling in diabetes.

Related Concept Videos

Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
12.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121